Market consultation on the purchase of the medicine Kaliumdihydrogenphosphat/Natriummonohydrogenphosphat-Dihydrat AI

TEDAS your procurement assistant

Ask a question about this procurement

t

This information is for market consultation purposes intended to prepare for a future public procurement.

Procurement subject

  • What is being purchased: Medicinal product Kaliumdihydrogenphosphat/Natriummonohydrogenphosphat-Dihydrat (602mg/360mg tablets). Indicative quantity – 700 units.
  • Main technical requirements:
    • Priority is given to registered medicinal products.
    • If the drug is supplied under the “Rules for the Acquisition of Named Medicinal Products”, the supplier must clearly indicate this.
    • Drugs must comply with the requirements of…
       
      To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

Kvietimas dalyvauti rinkos konsultacijoje.pdf

Rinkos konsultacijos klausimynas_2 priedas.docx

Techninė specifikacija (projektas)_1 priedas.pdf

Ready to get started?

Subscribe and enjoy all the benefits every day!